1 Transanal total mesorectal excision (TaTME): are we doing it for the right indication? An assessment of the external validity of published online video resources.

2 Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.

3 Robot-assisted versus conventional laparoscopic operation in anus-preserving rectal cancer: a meta-analysis.

4 Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

5 Short-term outcomes of laparoscopically assisted surgery for rectal cancer following neoadjuvant chemoradiotherapy: a single-center experience.

6 Should radical surgery for rectal cancer be offered to elderly population? A propensity-matching analysis on short- and long-term outcomes.

7 relationship between surgical procedure and spontaneous urination after rectal cancer surgery

8 optimal time intervals between preoperative radiotherapy or chemoradiotherapy and surgery in rectal cancer?

9 time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: a population study on 2094 patients

10 pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases

11 Laparoscopic colorectal surgery using low-pressure pneumoperitoneum combined with abdominal wall lift by placement of anchoring sutures around the camera port

12 Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives.

13 Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial.

14 Clinicopathologic Analysis of Five Patients with -Mutated Colorectal Cancer in a Single Korean Institute.

15 Metvan, bis(4,7-Dimethyl-1,10-phenanthroline)sulfatooxidovanadium(IV): DFT and Spectroscopic Study-Antitumor Action on Human Bone and Colorectal Cancer Cell Lines.

16 Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.

17 Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters

18 EGFR signaling in colorectal cancer: a clinical perspective

19 EGFR signaling in colorectal cancer: a clinical perspective

20 EGFR signaling in colorectal cancer: a clinical perspective

21 Hepatopulmonary Fistula in a Colorectal Cancer Patient

22 A Concise Review of Pelvic Radiation Therapy (RT) for Rectal Cancer with Synchronous Liver Metastases

23 Impact of Metabolic Syndrome Diagnosis and Its Treatment on Survival of Colorectal Cancer Patients

24 Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).

25 Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study.

26 Transcriptome and DNA Methylome Analysis in a Mouse Model of Diet-Induced Obesity Predicts Increased Risk of Colorectal Cancer

27 Implications of Isoprostanes and Matrix Metalloproteinase-7 Having Potential Role in the Development of Colorectal Cancer in Males

28 Determination of effective factors on geographic distribution of the incidence of colorectal cancer in Tehran using geographically weighted Poisson regression model.

29 Gastric environment-stable oral nanocarriers for in situ colorectal cancer therapy.

30 Linking primary care and community organizations to increase colorectal cancer screening rates: the HAPPI project.

31 Correlation of ultra-high field MRI with histopathology for evaluation of rectal cancer heterogeneity.

32 Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF-β1/ZEB1/miR-200c signaling pathway.

33 Investigating the Impact of Geographic Location on Colorectal Cancer Stage at Diagnosis: A National Study of the SEER Cancer Registry.

34 Value of intra-operative Doppler sonographic measurements in predicting post-operative anastomotic leakage in rectal cancer: a prospective pilot study.

35 [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].

36 A Population-Based Study of 90-Day Hospital Cost and Utilization Associated With Robotic Surgery in Colon and Rectal Cancer

37 A Matched Case-Control Analysis of Clinical Outcomes for Inflammatory Bowel Disease Patients with Rectal Cancer Treated with Pelvic Radiation Therapy.

38 SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.

39 Rethinking the Re-Prep: Attitudes Toward Noninvasive Colorectal Cancer Screening Tests After Inadequate Bowel Preparation.

40 Colorectal cancer guidelines seldom include the patient perspective.

41 Integrated Analysis of Oncogenic Networks in Colorectal Cancer Identifies GUCA2A as a Molecular Marker.

42 Predicting Overall Survival in Patients with Metastatic Rectal Cancer: a Machine Learning Approach.

43 Dietary changes adopted by Chinese colorectal cancer patients: A qualitative study.

44 The impact of screening on the survival of colorectal cancer in Shanghai, China: a population based study.

45 Evaluation of the usefulness of the simultaneous assay of fecal hemoglobin (Hb) and transferrin (Tf) in colorectal cancer screening - for the establishment of the Hb and Tf two-step cutoff assay (HTTC assay).

46 Patients' information needs and attitudes about post-treatment surveillance for colorectal cancer in the United States: a multi-perspective, mixed methods study.

47 Correction: Griffith, D.M., et al. Novel Improved Synthesis of HSP70 Inhibitor, Pifithrin-μ. In Vitro Synergy Quantification of Pifithrin-μ Combined with Pt Drugs in Prostate and Colorectal Cancer Cells. Molecules 2016, 21, 949

48 Personal and Neighborhood Attributes Associated with Cervical and Colorectal Cancer Screening in an Urban African American Population.

49 Geographical variation and factors associated with colorectal cancer mortality in a universal health care system.

50 Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.

51 The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort Study.

52 Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta-analysis.

53 Protective effect of the “food-microorganism-SCFAs” axis on colorectal cancer: from basic research to practical application

54 Utilization of the Caprini score in conjunction with thrombodynamic testing reduces the number of unpredicted postoperative venous thromboembolism events in patients with colorectal cancer.

55 Mediterranean diet adherence and risk of colorectal cancer: the prospective Netherlands Cohort Study.

56 Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel.

57 The Colorectal Cancer Screening Programme in the Basque Country: obtaining a good performance by means of professional collaboration

58 Human Colorectal Cancer Infrastructure Constructed by the Glycocalyx.

59 Supportive care needs of patients following treatment for colorectal cancer: risk factors for unmet needs and the association between unmet needs and health-related quality of life-results from the ColoREctal Wellbeing (CREW) study.

60 Preoperative anxiety in Chinese colorectal cancer patients: The role of social support, self-esteem and coping styles

61 Single-cell transcriptional profiling reveals the heterogenicity in colorectal cancer.

62 MicroRNA-193a and taxol combination: A new strategy for treatment of colorectal cancer.

63 Low colorectal cancer survival in the Mountain West state of Nevada: A population-based analysis.

64 Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4 colorectal cancer.

65 Predictive biomarkers of colorectal cancer.

66 Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis

67 Exam 1: Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis

68 Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.

69 Adjuvant chemotherapy in colorectal cancer: mournful, hopeful perpetual motion machine heads to dim light at end of tunnel.

70 Adjuvant Chemotherapy in Colorectal Cancer: Mournful, Hopeful Perpetual Motion Machine Heads to Dim Light at End of Tunnel

71 Patient-Reported Unmet Needs in Colorectal Cancer Survivors After Treatment for Curative Intent.

72 Design, Synthesis and Biological Activity Evaluation of S-Substituted 1H-5-Mercapto-1,2,4-Triazole Derivatives as Antiproliferative Agents in Colorectal Cancer

73 Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.

74 Synthesis, characterization, anti-proliferative properties and DNA binding of benzochromene derivatives: Increased Bax/Bcl-2 ratio and caspase-dependent apoptosis in colorectal cancer cell line.

75 Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.

76 Evaluation of MGP gene expression in Colorectal Cancer.

77 Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population.

78 Exacerbation of Dermatomyositis with Recurrence of Rectal Cancer: A Case Report

79 Short-term efficacy of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: a randomized controlled trial.

80 Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

81 The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.

82 Information needs and information seeking behaviour of patients during follow-up of colorectal cancer in the Netherlands.

83 Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy

84 A nationwide study on the incidence of mesenteric ischaemia after surgery for rectal cancer demonstrates an association with high arterial ligation.

85 Klotho-mediated targeting of CCL2 suppresses the induction of colorectal cancer progression by stromal cell senescent microenvironments.

86 Inhibitory Effects of Pectinase-Treated Prunus Mume Fruit Concentrate on Colorectal Cancer Proliferation and Angiogenesis of Endothelial Cells.

87 MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.

88 Colorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis.

89 Risk of colorectal cancer in users of bisphosphonates: analysis of population-based electronic health records.

90 Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.

91 Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition.

92 Effect and mechanism of vitamin D on the development of colorectal cancer based on intestinal flora disorder.

93 The case for philanthropic investment to increase colorectal cancer screening rates: A novel paradigm to address a public health challenge.

94 Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.

95 Robot-assisted versus conventional laparoscopic operation in anus-preserving rectal cancer: a meta-analysis

96 Development of Deep Learning Algorithm for Detection of Colorectal Cancer in EHR Data.

97 The impact of travel time on colorectal cancer stage at diagnosis in a privately insured population.

98 Evaluation of Rectal Cancer Circumferential Resection Margin Using Faster Region-based Convolutional Neural Network in High-Resolution Magnetic Resonance Images.

99 Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis.

100 Expectations of patients with colorectal cancer towards nursing care– a thematic analysis

101 Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer.

Keyword Connections

Journals

Research Groups

Bibliographies